Home
 /
Papers
 /
Neuroscience
 /
Striatal ensembles specify and control granular forelimb actions
Preprint
Open access
V1
Top 1% · Validated by QED

Striatal ensembles specify and control granular forelimb actions

Ines Rodrigues-Vaz, Vivek R. Athalye, Darcy S. Peterka +1 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.03.692128
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing D1- and D2-MSN ensembles causally control action identity—not merely vigor—at the granularity of distinct muscle patterns, this study overturns the canonical opponent-pathway model and reframes the cellular basis of specific movement disorders.

QED claims analysis

Summary

Action-specific ensembles of both D1- and D2-medium spiny neurons in the dorsolateral striatum equally encode the identity of granular forelimb actions distinguished by distinct muscle activation patterns, and closed-loop optogenetic stimulation of these ensembles causally increases force production selectively for the congruent action, establishing that striatal ensembles control specific ongoing actions rather than providing general motor invigoration.

See full analysis
Main Claim 1 –

Push and pull recruit same muscles with distinct EMG patterns

Supporting evidence

  • Mice learn to increase reinforced actions in isometric task
Main Claim 2 –

D1 and D2 MSNs equally encode isometric action identity

Main Claim 3 –

Congruent ensemble stimulation selectively increases ongoing action force

Supporting evidence

  • Holographic stimulation activates action ensembles and biases striatal encoding

Abstract

The ability of the brain to control specific fine actions is crucial for survival. Although striatal dysfunction underlies numerous movement disorders, its activity has classically been studied in the context of movement reinforcement and invigoration. Recent studies have revealed that striatal activity encodes specific whole-body and forelimb movements. However, it is unclear if this activity actually controls specific movements. We developed a closed-loop system to identify and manipulate action-specific neuronal ensembles in real time using holographic optogenetics through a GRIN lens. We designed an isometric force task in which mice performed push or pull actions on an immobile joystick without overt kinematics—actions that engage the same forelimb muscles but with different activation patterns. Using 2-photon calcium imaging, we simultaneously recorded D1- and D2-medium spiny neurons (MSNs) in the dorsolateral striatum - classically viewed as promoting versus inhibiting movement – and found that both populations equally encoded isometric action identity. Stimulation of action-specific D1- and D2-MSN ensembles increased ongoing force, but only when the stimulated ensemble was congruent with the ongoing action. These results reveal that specific ensembles of D1- and D2-MSNs control specific actions, as granular as distinct muscle activation patterns of the same forelimb. These findings provide a novel framework for understanding how striatal dysfunction can produce highly specific movement impairments in Huntington’s disease and dystonia.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?